Industry Webinars

Share this page

SNMMI Industry Partners Webinar Series

Access live and on-demand webinars, designed to connect our industry partners with the nuclear medicine and molecular imaging community. Interested in sponsoring a future Industry Partners webinar? Contact Sharon Gleason for details.

Upcoming Industry Webinars

Date	Time (ET)	Webinar Title	Details	Hidden
There are no records.

SNMMI 2023 Annual Meeting On-Demand Satellite Symposia

Hear directly from SNMMI's industry partners in these popular one-hour virtual presentations recorded at the 2023 Annual Meeting.
Note: CE Credit is not offered for these Satellite Symposia.

Company	Symposia Title
Actinium Pharmaceuticals	Delivering High-dose Targeted Radiotherapy with Safety and Tolerability of ReducedIntensityConditioning with lomab-B (I131-apamistamab) in the SIERRA Study: the Nuclear Medicine Perspective
Bayer	The Past, Present and Future of Xofigo: The First and Only Alpha Targeted Therapy For Advanced Prostate Cancer
Blue Earth Diagnostics	PSMA Pet: Imaging Engineered
Cyclomedica	Unlocking the New Era in Nuclear Pulmonology
Eisai	Timely Alzheimer's Disease Diagnosis forClinical Management: The Integrated Role of PET Imaging
GE Healthcare	Building Your Future in Theranostics
ITM	Investing Into the Future of Theranostics: Aligning Supply to the Clinical Needs
Lantheus	PSMA PET Imaging: Five Years of Experience from Research to Clinical Use
Lantheus	PSMA PET in Prostate Cancer: A Case-Based Discussion
PeerView Live	Navigating the New Era of Molecularly-Defined Care in Alzheimer's Disease: Applying Nuclear Medicine to Quantify Neuropathology and Improve Diagnostic Accuracy in the Earliest Stages of the AD Continuum
Pfizer	Utilizing Imaging to Identify Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) for Appropriate Diagnosis and Treatment
Siemens Healthineers	Expanding Access to Care with Modern Molecular Imaging
Siemens Healthineers	Advancing Patient Care with Total-body PET/CT
SOFIE	FAP Ligands for Imaging and Therapy
Spectrum Dynamics	Spectrum Dynamics Medical: Reaching Higher Peaks in Digital SPECT Imaging
United Imaging	Unleashing the Power of Total-Body PET/CT: Reflections on 5 Years of Progress
United Imaging	Advancing Precision Medicine: Unprecedented PET/CT Technology for Clinical Molecular Imaging

SNMMI 2022 Annual Meeting On-Demand Satellite Symposia

Hear directly from SNMMI's industry partners in these popular one-hour virtual presentations recorded at the 2022 Annual Meeting.
Note: CE Credit is not offered for these Satellite Symposia.

Company	Symposia Title
Blue Earth Diagnostics	¹⁸F-rhPSMA-7.3, a unique investigational prostate-specific membrane antigen (PSMA)-targeted PET imaging agent for men with prostate cancer.
Cyclomedica	Unlocking the New Era in Nuclear Pulmonology
GE Healthcare	Shooting for Mars through Accelerated Research and Development in Molecular Imaging, and Regulatory Hurdles in Getting There
GE Healthcare	Establishing a Theragnostics Program: Practical Considerations
ImaginAb	An early look at immune responses - How can zirconium 89-Df crefmirlimab advance our understanding?
Lantheus	Case Review Series
Medical Education Resources/Efficient	Why Now? The New Paradigm and Rising Role of Nuclear Medicine in Alzheimer’s Disease
SOFIE/Clovis Oncology/POINT Biopharma	FAP Ligands for Imaging and Therapy
Siemens Healthineers	Siemens Healthineers Luncheon Symposium
Spectrum Dynamics	Next Generation SPECT Imaging
United Imaging	Translational Cancer Imaging Research in the Era of Precision Medicine

From Our Industry Alliance Partners

Access great online learning content from SNMMI's Value Initiative Industry Partners:

New! Real World Considerations for I-131 MIBG
Nuclear medicine experts Dr. Erik Mittra, MD, PhD, and Adam Brown, BS, NMTCB, RT, provide a review of the clinical evidence surrounding the approval of HSA I-131-MIBG as well as best practices on patient preparation, execution of dosimetry and therapy, and monitoring and identification of adverse events.
Hereditary Pheochromocytoma and Paraganglioma: Strategies for Screening and Surveillance
Through discussions with a patient who is SDHB positive, Dr Lauren Fisbein will explain the significance of mutations and associated tumor risks.
Targeted Therapeutics for Metastatic or Unresectable Pheochromocytoma and Paraganglioma
Through discussions with a patient who has experienced malignant pheochromocytoma, Dr. Dan Pryma provides guidance on treatment options for metastatic disease.

SNMMI 2021 Annual Meeting On-Demand Satellite Symposia

Hear directly from SNMMI's industry partners in these popular one-hour virtual presentations recorded at the 2021 Annual Meeting.
Note: CE Credit is not offered for these Satellite Symposia.

Company	Symposia Title
Advanced Accelerator Applications	Novartis’ Commitment to Targeted Radioligands in Oncology
Blue Earth Diagnostics	The Role of PET in Post-Prostatectomy Radiotherapy
Cardinal Health	Theranostics and the Future: How to Prepare for these Novel Radiopharmaceuticals
Cyclomedica	Technegas® …. A new era in Nuclear Pulmonology
GE Healthcare	Neurology and Nuclear Medicine: Working Together for an Optimal Dementia Diagnosis
GE Healthcare	True Digital SPECT/CT: Precision Imaging at the Speed of Tomorrow
Jubilant Radiopharma	Cardiac PET: Practical Considerations in Starting a Program
Lantheus	Practical Applications and Clinical Utility of an 18F PSMA-Targeted PET Imaging Agent: Implications for Urology and Radiation Oncology
PETNET Solutions	Maximizing the Clinical Impact of Receptor Imaging in Breast Cancer
Siemens Healthineers	Biograph Vision Quadra First Impressions – A quantum leap in PET/CT imaging
Telix Pharmaceuticals	PSMA-PET/CT: Integrating Imaging with the Care Team
United Imaging	Advancing the Clinical Frontiers of Ultra-high-resolution Digital PET